reported that anti-CD38 CAR-T cells displayed time- and quantity-dependent cytotoxicity to AML cell lines with high expression of CD38 and had a selective killing effect on AML cell lines with partial or low expression of CD38 but had no effect on CD38-negative cells (70). This evidence concerns the gene CD38 and acute myeloid leukemia.